Atsuko Fujisawa

Title: Innovations of Atsuko Fujisawa

Introduction

Atsuko Fujisawa is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of proteins involved in cellular processes. With a total of 2 patents, her work has garnered attention in the scientific community.

Latest Patents

Fujisawa's latest patents focus on a novel protein known as Meltrins. The purpose of this invention is to provide a protein that plays a crucial role in the adhesion and fusion of myoblasts during the formation of myotubes. Meltrins is characterized as a membrane protein that exhibits fusion, adhesion, and aggregation activity of cells, especially myoblasts. The invention also encompasses polypeptides of their domains, DNAs encoding them, antisense RNA for these DNAs, various antibodies to Meltrins and the polypeptides of their domains, expression vectors containing these DNAs, and transformants created using these vectors. Additionally, the patent details the process for producing Meltrins and the polypeptides of their domains, as well as medical compositions that include Meltrins or antagonists against them as effective ingredients.

Career Highlights

Fujisawa is currently associated with Mochida Pharmaceutical Co., Ltd., where she continues to advance her research and innovations. Her work has been instrumental in enhancing the understanding of cellular mechanisms and developing potential therapeutic applications.

Collaborations

Some of her notable coworkers include Naoki Ogawa and Kamon Shirakawa, who have collaborated with her on various projects.

Conclusion

Atsuko Fujisawa's contributions to the field of biotechnology through her patents and research are noteworthy. Her work on Meltrins exemplifies the innovative spirit that drives advancements in medical science.